ArticleJournal of experimental & clinical cancer research : CR2022

Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial.

Xiaotao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.